Learn How the Transcreener® ADP2 Assay Can Determine Drug-Kinase Residence Time

Our newest application note provides a protocol and experimental example for the use of the Transcreener ADP2 FP Assay to determine the residence time of a drug (or drug candidate) during its interaction with a kinase.  The duration of residence time can be highly relevant for assessing the durable pharmacologic effects of a drug candidate.

Want to learn more? View the application note here.